prostate cancer
prostate cancer with http://www.medical-mailings.com

prostate cancer

medical mailings

News for 18-Dec-11

Source: MedicineNet Diabetes General
Apnea Treatment Might Reduce Signs of Heart Disease Risk

Source: MedicineNet Asthma General
More Children Using Preventive Asthma Drugs: Study

Source: MedicineNet Diabetes General
Brief, Intense Exercise Lowers Blood Sugar, Small Study Finds

Source: MedicineNet Asthma General
Chronic Disease May Up Out-of-Pocket Costs for Insured

Source: MedicineNet Asthma General
Experts Debate Tylenol's Safety for Asthmatic Kids

Source: MedicineNet Asthma General
Health Tip: Focus on Preconception Health

Source: MedicineNet Asthma General
Health Highlights: Dec. 15, 2011

Source: MedicineNet Diabetes General
Vitamin D Levels Tied to Diabetes Risk in Obese Kids

Source: MedicineNet Asthma General
Doctors in a Bind When Parents Want to Delay, Skip Vaccines

Source: MedicineNet Diabetes General
Chewing Khat Linked to Stroke, Death

Search the Web
prostate cancer
online reference resources,
md jobs
patient
obgyn
gynecological ultrasound
doctor who
health news
joyce lines
health care

The Best prostate cancer website

All the prostate cancer information you need to know about is right here. Presented and researched by http://www.medical-mailings.com. We've searched the information super highway far and wide to provide you with the best prostate cancer site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
prostate cancer.

prostate cancer

medical mailings, email campaigns
Need information on Medical Mailings? Our links will provide you with information on all type of type of Medical Mailings for Physicians over the internet including email and snail mail. For conferencing services to go with your email campagin go to Meetings on the Net - http://www.meetingsonthenet.com
medical mailings, email campaigns

Corporate news or equity market information on prostate cancer companies will be found at websites of brokers or share traders. Articles of this kind can give you a different perspective on prostate cancer which enable you to identify solid, growing prostate cancer organizations compared to fly-by-night operators.

It may surprise you to learn that prostate cancer companies will happily add you to their press release circulation list so that you can keep right up to date with developments in the field of prostate cancer including new prostate cancer products which may be of particular interest to consumers like yourself.

prostate cancer

medical mailings, email campaigns
Need information on Medical Mailings? Our links will provide you with information on all type of type of Medical Mailings for Physicians over the internet including email and snail mail. For conferencing services to go with your email campagin go to Meetings on the Net - http://www.meetingsonthenet.com
medical mailings, email campaigns

You can spend a few hours looking on the Net for information about prostate cancer or you can take advantage of the research we have done for you. There are literally hundreds of thousands of web pages with some kind on information on prostate cancer but much is of little value.

Jeeves is a good source for information about prostate cancer but you must filter through the commercials for prostate cancer and determine if that is really what you want. This means you must make a decision on the value from this particular prostate cancer store. You are welcome to spend your valuable time in this research or you can rely on the fact that we have done it for you and click the links on the left side of this page.

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

 by: ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)


ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN


Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1×104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1×104 - 1×107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

  1. HBV-DNA response after the treatment.

  2. Lasting HBV-DNA response (six months after withdrawal).

Criterion of Therapeutic Effect:

  1. If HBV-DNA volume 1×104 cp/mL: 4/25 (16%)

  2. Lasting response:

HBV-DNA volume 1×104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it < 1×102 cp/mL). The testing range of this testing method is 1×102 - 1×107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient's blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com


Or, contact:


William Yip cs@vigconic.com


5/F, Cheung Wah Building, Sheung Heung Rd,


Kowloon, Hong Kong


Tel: 852-27656200


Fax: 852-27645314

About The Author

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China


webmaster@vigconic.com

Google

http://www.gomailings.com/
Medical Meetings | Medical Presentations | Medical Meetings On The Net | Medical Newscast | MD Meetings

Medical Newscast   Take It Correctly   Listen On The Net